NCT00006134|Completed
Loading search results
Sponsor study identifier
Secondary identifiers
observational
300
1 country
3
Study Start
September 1993
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedOBJECTIVES: I. Continue yearly ascertainment visits of all patients of the established Lupus in Minority Populations: Nature vs Nurture (LUMINA) study cohort. II. Recruit into the LUMINA cohort newly diagnosed patients with systemic lupus erythematosus (SLE). III. Determine the impact of additional major histocompatibility complex (MHC) and non-MHC genetic factors not previously examined, specifically tumor necrosis factor, mannose binding protein, interleukin-1 receptor antagonist, and bcl-2, on the course and outcome of SLE. IV. Refine the assessment of those clinical and behavioral-cultural factors found to be important predictors of disease activity, damage, and functioning, thus far in these patients. V. Determine the relationships among disease activity, disease damage, and physical and mental functioning in these patients as the SLE progresses and the factors that predict them.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 1993
Date type not reportedThis date has not been verified as actual or estimated.
August 3, 2000
Actual (reported)August 4, 2000
Actual (reported)Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
University of Alabama Comprehensive Cancer Center
Birmingham, Alabama, 35294, United States
University of Texas Medical Branch
Galveston, Texas, 77555-0209, United States
University of Texas Health Science Center - Houston
Houston, Texas, 77225, United States
Graciela S. Alarcon
University of Alabama at Birmingham
First Submitted
August 3, 2000
First Posted
August 4, 2000
Study Start
September 1993
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
June 24, 2005
Record last verified: 2003-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus